abstract |
Corneal epithelial disorders or conjunctival disorders containing an agent that selectively inhibits COX-2 selected from etodolak, N- (2- (cyclohexyloxy) -4-nitrophenyl) methanesulfonamide, and melooxycamp Anti-inflammatory eye drops with little anti-inflammatory effect. |